5Bjorn Blomberg,Sergio Spinaci,Bernard Fourie,et al.The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis[J].Bulletin of the World Health Organization,2001,79 (1):61-68
6International Union against Tuberculosis and Lung Disease.Anti-tuberculosis regiments of the chemotherapy.Recommendations from the committee on treatment of the International Union Tubere Lung Dis,1998,63:60-64
7World Heath Organization Tuberculosis Program.Treatment of tuberculosis guidelines for national procams[M].Geneva:WHO,1993
8Hongkong Chest Service/BMRC.Acceptability,compliance,and adverse reactions when isoniazid,rifampin,and pyrazinamide are given as a combined formulation or separately during three times weekly antituberculosis chemotherapy[J].Am Rev Respir Dis,1989,64:36
9Chaulet P,Boulahbal F.Clinical trial of a combination of three drugs in fixed proportions for the treatment of tuberculosis[J].Tuberculosis and Lung Disease,1995,76:407-412
10Turktas H, Unsal M, Tulek N,et al. Hepatotoxicity of anti-tuberculosis therapy (rifampicin,isoniazid and pyrazinamide)or viral hepatitis[J]. Tuberc Lung Dis, 1994,75( 1 ) :58-60.
5Marra F, Marra CA, Bruchet N, et al. Adverse drug reactions associated with first line anti-tuberculosis drug regimens. Int J Tubere Lung Dis, 2007,11 (8) : 868-875.
